InsiderClue
← All stocks

Bicara Therapeutics Inc.

BCAX Net buying
CIK 0002023658 #2204 in the set updated 17 Sep 2026
Bought (12 mo)
$4.80M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$13.54M
$87.52K on a plan · $13.45M straight out of an exercise
Sold at will
$0.00
0 of 72 sales
Net
−$8.74M
+$4.80M against sales at will

By person

7 insiders · 79 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$4.80M (1)
—
+$4.80M
4,603,418
6.96%
$107.88M
+7.0%
Cohlhepp Ryan
President, COO & Interim CEO
—
$4.60M (29) scheduled
−$4.60M
181,641
0.2745%
$4.26M
−17.9%
Mazumdar Claire
Chief Executive Officer
—
$4.06M (17) scheduled
−$4.06M
362,152
0.5473%
$8.49M
+16.9%
Hyep Ivan
Chief Financial Officer
—
$3.24M (17) scheduled
−$3.24M
129,855
0.1962%
$3.04M
−10.7%
Raben David
Chief Medical Officer
—
$1.15M (8) scheduled
−$1.15M
55,286
0.0835%
$1.30M
+55.7%
Meisner Lara
Chief Legal Officer
—
$498.65K (1) scheduled
−$498.65K
0
0.0000%
$0.00
—
Flynn James E
10% owner
—
—
—
897,587
1.36%
$21.03M
—

Individual transactions

79
Insider
Date
Role
Action
Shares
Price
Amount
Cohlhepp Ryan
8 Sep 2026
President, COO & Interim CEO
Sold after exercise
3,442
$23.43
$80.66K
Cohlhepp Ryan
8 Sep 2026
President, COO & Interim CEO
Sold after exercise
14,058
$22.77
$320.05K
Cohlhepp Ryan
10 Aug 2026
President and COO
Sold after exercise
18,750
$27.98
$524.53K
Mazumdar Claire
10 Aug 2026
Chief Executive Officer
Sold after exercise
10,000
$27.98
$279.75K
Hyep Ivan
10 Aug 2026
Chief Financial Officer
Sold after exercise
12,500
$27.97
$349.59K
Mazumdar Claire
10 Jul 2026
Chief Executive Officer
Sold after exercise
28
$29.68
$831.04
Mazumdar Claire
10 Jul 2026
Chief Executive Officer
Sold after exercise
9,972
$28.42
$283.37K
Cohlhepp Ryan
9 Jul 2026
President and COO
Sold on a plan
536
$29.00
$15.54K
Hyep Ivan
8 Jul 2026
Chief Financial Officer
Sold after exercise
830
$30.31
$25.16K
Hyep Ivan
8 Jul 2026
Chief Financial Officer
Sold after exercise
4,413
$29.82
$131.62K
Hyep Ivan
8 Jul 2026
Chief Financial Officer
Sold after exercise
22,757
$28.60
$650.90K
Cohlhepp Ryan
8 Jul 2026
President and COO
Sold after exercise
1,075
$30.35
$32.63K
Cohlhepp Ryan
8 Jul 2026
President and COO
Sold after exercise
4,306
$29.80
$128.30K
Cohlhepp Ryan
8 Jul 2026
President and COO
Sold after exercise
22,833
$28.76
$656.65K
Hyep Ivan
21 May 2026
Chief Financial Officer
Sold after exercise
9,200
$20.42
$187.88K
Mazumdar Claire
18 May 2026
Chief Executive Officer
Sold after exercise
2,978
$20.35
$60.60K
Mazumdar Claire
18 May 2026
Chief Executive Officer
Sold after exercise
12,022
$19.96
$239.98K
Cohlhepp Ryan
15 May 2026
President and COO
Sold after exercise
4,500
$20.29
$91.31K
Cohlhepp Ryan
15 May 2026
President and COO
Sold after exercise
8,000
$20.29
$162.34K
Raben David
27 Apr 2026
Chief Medical Officer
Sold after exercise
5,500
$22.88
$125.83K
Hyep Ivan
21 Apr 2026
Chief Financial Officer
Sold after exercise
9,200
$23.00
$211.61K
Mazumdar Claire
20 Apr 2026
Chief Executive Officer
Sold after exercise
15,000
$23.61
$354.15K
Mazumdar Claire
16 Apr 2026
Chief Executive Officer
Exercised, kept
7,080
$5.45
$38.61K
Mazumdar Claire
16 Apr 2026
Chief Executive Officer
Exercised, kept
7,454
$3.79
$28.25K
Mazumdar Claire
16 Apr 2026
Chief Executive Officer
Exercised, kept
8,226
$4.44
$36.50K
Cohlhepp Ryan
15 Apr 2026
President and COO
Sold after exercise
4,500
$23.01
$103.53K
Cohlhepp Ryan
15 Apr 2026
President and COO
Sold after exercise
8,000
$23.01
$184.06K
Raben David
25 Mar 2026
Chief Medical Officer
Sold after exercise
5,500
$18.95
$104.23K
Hyep Ivan
23 Mar 2026
Chief Financial Officer
Sold after exercise
9,200
$18.52
$170.35K
Mazumdar Claire
20 Mar 2026
Chief Executive Officer
Sold after exercise
1,596
$18.95
$30.25K
Mazumdar Claire
19 Mar 2026
Chief Executive Officer
Sold after exercise
6,905
$18.78
$129.70K
Mazumdar Claire
18 Mar 2026
Chief Executive Officer
Sold after exercise
6,499
$18.84
$122.41K
Cohlhepp Ryan
16 Mar 2026
President and COO
Sold after exercise
4,500
$19.66
$88.46K
Cohlhepp Ryan
16 Mar 2026
President and COO
Sold after exercise
8,000
$19.66
$157.26K
Mazumdar Claire
9 Mar 2026
Chief Executive Officer
Sold after exercise
36,766
$19.17
$704.66K
Mazumdar Claire
6 Mar 2026
Chief Executive Officer
Sold after exercise
3,817
$18.75
$71.57K
Mazumdar Claire
5 Mar 2026
Chief Executive Officer
Sold after exercise
1,786
$18.74
$33.46K
Raben David
4 Mar 2026
Chief Medical Officer
Sold after exercise
16,300
$18.52
$301.92K
Hyep Ivan
4 Mar 2026
Chief Financial Officer
Sold after exercise
2,963
$18.25
$54.06K
Mazumdar Claire
4 Mar 2026
Chief Executive Officer
Sold after exercise
2,631
$18.73
$49.29K
Raben David
3 Mar 2026
Chief Medical Officer
Sold after exercise
200
$18.45
$3.69K
Hyep Ivan
3 Mar 2026
Chief Financial Officer
Sold after exercise
13,555
$18.22
$246.91K
Cohlhepp Ryan
3 Mar 2026
President and COO
Sold after exercise
4,500
$18.16
$81.73K
Cohlhepp Ryan
3 Mar 2026
President and COO
Sold after exercise
12,892
$18.16
$234.16K
RA CAPITAL MANAGEMENT, L.P.
26 Feb 2026
Director
Buy indirect
300,000
$16.00
$4.80M
Cohlhepp Ryan
25 Feb 2026
President and COO
Sold after exercise
523
$18.04
$9.43K
Cohlhepp Ryan
25 Feb 2026
President and COO
Sold after exercise
3,108
$18.04
$56.07K
Hyep Ivan
22 Jan 2026
Chief Financial Officer
Sold after exercise
1,882
$18.15
$34.16K
Cohlhepp Ryan
22 Jan 2026
President and COO
Sold on a plan
3,828
$18.10
$69.30K
Cohlhepp Ryan
15 Jan 2026
President and COO
Sold on a plan
149
$18.02
$2.68K
Raben David
26 Dec 2025
Chief Medical Officer
Exercised, kept
19,789
$3.79
$75.00K
Cohlhepp Ryan
26 Dec 2025
President and COO
Exercised, kept
25,000
$4.44
$110.92K
Hyep Ivan
22 Dec 2025
Chief Financial Officer
Sold after exercise
9,200
$18.31
$168.49K
Mazumdar Claire
16 Dec 2025
Chief Executive Officer
Exercised, kept
29,500
$5.45
$160.88K
Cohlhepp Ryan
15 Dec 2025
President and COO
Sold after exercise
4,500
$18.68
$84.08K
Cohlhepp Ryan
15 Dec 2025
President and COO
Sold after exercise
8,000
$18.68
$149.47K
Raben David
25 Nov 2025
Chief Medical Officer
Sold after exercise
906
$18.84
$17.07K
Raben David
25 Nov 2025
Chief Medical Officer
Sold after exercise
4,594
$18.84
$86.56K
Raben David
24 Nov 2025
Chief Medical Officer
Sold after exercise
5,500
$18.45
$101.48K
Mazumdar Claire
24 Nov 2025
Chief Executive Officer
Sold after exercise
41,163
$18.86
$776.43K
Hyep Ivan
24 Nov 2025
Chief Financial Officer
Sold after exercise
17,795
$18.55
$330.09K
Cohlhepp Ryan
21 Nov 2025
President and COO
Sold after exercise
4,500
$18.05
$81.21K
Cohlhepp Ryan
21 Nov 2025
President and COO
Sold after exercise
8,000
$18.05
$144.38K
Hyep Ivan
21 Nov 2025
Chief Financial Officer
Sold after exercise
605
$18.15
$10.98K
Mazumdar Claire
16 Oct 2025
Chief Executive Officer
Sold after exercise
24,103
$18.83
$453.76K
Mazumdar Claire
15 Oct 2025
Chief Executive Officer
Sold after exercise
13,289
$18.84
$250.39K
Cohlhepp Ryan
15 Oct 2025
President and COO
Sold after exercise
4,500
$18.16
$81.70K
Cohlhepp Ryan
15 Oct 2025
President and COO
Sold after exercise
8,000
$18.16
$145.24K
Mazumdar Claire
13 Oct 2025
Chief Executive Officer
Sold after exercise
11,445
$18.92
$216.55K
Hyep Ivan
9 Oct 2025
Chief Financial Officer
Sold after exercise
6,415
$18.23
$116.93K
Raben David
9 Oct 2025
Chief Medical Officer
Sold after exercise
22,000
$18.45
$405.90K
Hyep Ivan
8 Oct 2025
Chief Financial Officer
Sold after exercise
5,627
$18.21
$102.46K
Cohlhepp Ryan
7 Oct 2025
President and COO
Sold after exercise
2,900
$18.06
$52.37K
Cohlhepp Ryan
7 Oct 2025
President and COO
Sold after exercise
8,000
$18.06
$144.47K
Hyep Ivan
7 Oct 2025
Chief Financial Officer
Sold after exercise
18,244
$18.22
$332.39K
Cohlhepp Ryan
6 Oct 2025
President and COO
Sold after exercise
15,600
$18.06
$281.67K
Cohlhepp Ryan
6 Oct 2025
President and COO
Sold after exercise
24,000
$18.06
$433.33K
Hyep Ivan
6 Oct 2025
Chief Financial Officer
Sold after exercise
6,514
$18.17
$118.36K
Meisner Lara
29 Sep 2025
Chief Legal Officer
Sold after exercise
33,807
$14.75
$498.65K

What was left out

Form 4 filings counted 62
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 69
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 677,756
History held since 16 Sep 2024